Intellia Therapeutics
NTLA
#6055
Rank
โ‚ฌ0.62 B
Marketcap
6,05ย โ‚ฌ
Share price
-3.77%
Change (1 day)
-73.75%
Change (1 year)

EPS for Intellia Therapeutics (NTLA)

EPS in 2023 (TTM): -5,18ย โ‚ฌ

According to Intellia Therapeutics's latest financial reports the company's current EPS (TTM) is -4,98ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -5,64ย โ‚ฌ a decrease over its 2021 EPS that were of -3,43ย โ‚ฌ.

EPS history for Intellia Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-5,18ย โ‚ฌ-8.08%
2022-5,64ย โ‚ฌ64.36%
2021-3,43ย โ‚ฌ56.67%
2020-2,19ย โ‚ฌ13.21%
2019-1,93ย โ‚ฌ6.53%
2018-1,82ย โ‚ฌ6.99%
2017-1,70ย โ‚ฌ71.4%
2016-0,99ย โ‚ฌ54.62%
2015-0,64ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,99ย โ‚ฌ-60.07%๐Ÿ‡บ๐Ÿ‡ธ USA